These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20863736)

  • 21. The IRF5 polymorphism in type 1 diabetes.
    Qu HQ; Marchand L; Grabs R; Polychronakos C
    J Med Genet; 2007 Oct; 44(10):670-2. PubMed ID: 17557928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus.
    Richez C; Blanco P; Rifkin I; Moreau JF; Schaeverbeke T
    Joint Bone Spine; 2011 Mar; 78(2):124-30. PubMed ID: 20961794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation and role of the transcription factor IRF5 in innate immune responses and systemic lupus erythematosus.
    Ban T; Sato GR; Tamura T
    Int Immunol; 2018 Oct; 30(11):529-536. PubMed ID: 29860420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate immunity in the lungs.
    Martin TR; Frevert CW
    Proc Am Thorac Soc; 2005; 2(5):403-11. PubMed ID: 16322590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptors as targets for immune disorders.
    Keogh B; Parker AE
    Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate (over)immunity and adaptive autoimmune disease.
    Recher M; Lang KS
    Curr Top Microbiol Immunol; 2006; 305():89-104. PubMed ID: 16724802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.
    Honda K; Takaoka A; Taniguchi T
    Immunity; 2006 Sep; 25(3):349-60. PubMed ID: 16979567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Toll like receptor-activated dendritic cells in the development of autoimmunity.
    Granucci F; Zanoni I
    Front Biosci; 2008 May; 13():4817-26. PubMed ID: 18508547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLRs and chronic inflammation.
    Ospelt C; Gay S
    Int J Biochem Cell Biol; 2010 Apr; 42(4):495-505. PubMed ID: 19840864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune interventions of human diseases through toll-like receptors.
    Coban C; Ishii KJ; Akira S
    Adv Exp Med Biol; 2009; 655():63-80. PubMed ID: 20047036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SUMO proteins: Guardians of immune system.
    Adorisio S; Fierabracci A; Muscari I; Liberati AM; Ayroldi E; Migliorati G; Thuy TT; Riccardi C; Delfino DV
    J Autoimmun; 2017 Nov; 84():21-28. PubMed ID: 28919255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.
    Zhang Y; Li H
    Physiology (Bethesda); 2017 May; 32(3):210-223. PubMed ID: 28404737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of toll-like receptors in chronic inflammation.
    Drexler SK; Foxwell BM
    Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity.
    Baccala R; Hoebe K; Kono DH; Beutler B; Theofilopoulos AN
    Nat Med; 2007 May; 13(5):543-51. PubMed ID: 17479100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease.
    Zhao GN; Jiang DS; Li H
    Biochim Biophys Acta; 2015 Feb; 1852(2):365-78. PubMed ID: 24807060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immunity: cells, receptors, and signaling pathways.
    Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2005; 53(3):245-53. PubMed ID: 15995585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirements for innate immune pathways in environmentally induced autoimmunity.
    Pollard KM; Kono DH
    BMC Med; 2013 Apr; 11():100. PubMed ID: 23557436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-Like Receptor Pathways in Autoimmune Diseases.
    Chen JQ; Szodoray P; Zeher M
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):1-17. PubMed ID: 25687121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model.
    Duffau P; Menn-Josephy H; Cuda CM; Dominguez S; Aprahamian TR; Watkins AA; Yasuda K; Monach P; Lafyatis R; Rice LM; Kenneth Haines G; Gravallese EM; Baum R; Richez C; Perlman H; Bonegio RG; Rifkin IR
    Arthritis Rheumatol; 2015 Dec; 67(12):3146-57. PubMed ID: 26315890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and functional characterization of interferon regulatory factors (irf2, irf7 and irf9) in the blunt snout bream (Megalobrama amblycephala).
    Zhan FB; Liu H; Lai RF; Jakovlić I; Wang WM
    Dev Comp Immunol; 2017 Feb; 67():239-248. PubMed ID: 27677680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.